Drug counterfeiting is an scourge that involves multinational criminals and middlemen who illicitly divert the drug from the supply chain. This problem is not due to the failures of insurers or manufacturers, but of enforcement of the law and bad policy. By declaring a shortage of weight-loss drugs, the FDA opened the floodgates to compounders, who began hawking drugs of varying quality. As these drugs have now entered the legitimate supply chain, expanding access would do more harm than good.